Short answer
Aquestive Therapeutics, Inc. (AQST) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Three Class II nominees elected to three-year terms ending at the 2029 annual meeting.
Aquestive Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Three Class II nominees elected to three-year terms ending at the 2029 annual meeting
- Executive compensation advisory vote approved for a one-year frequency
- KPMG LLP ratified as independent auditor for fiscal 2026
- Director elections included 37,465,582 broker non-votes, limiting voting participation but not affecting outcomes
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aquestive Therapeutics, Inc. 8-K filings
Get the next AQST 8-K as it lands
Follow AQST for push alerts, or ask the research agent what this filing means.